Abstract:Human tissue factor pathway inhibitor (TFPI) is a native specific inhibitor of extrinsic pathway of coagulation in vivo. As a kind of deletion variant which only contains N-terminus, K1 and K2 of TFPI, TFPI 1-161 is an ideal control molecule in the research of structure and function of TFPI. In this article, we not only investigated the methods of expression and purification, but also detected characteristics of TFPI 1-161. Using plasmid pGEM-3Zf(-)-TFPI as a template, DNA of TFPI 1-161 was obtained by PCR and cloned into plasmid pPIC9K to construct expression plasmid pPIC9K-TFPI 1-161. By force of screening multi-copy transformant and optimizing ferment condition, TFPI 1-161 was highly expressed in Pichia pastoris GS115 for the first time and the final yield after purification was increased more than 20-fold comparing with Saccharomyces cerevisiae. TFPI 1-161 was expressed as two different molecular weight proteins namely TFPI 1-161(24kD) and TFPI 1-161(27kD) because of difference of glycosylation. Their isoelectric points were 4.8 and 4.9 respectively. They were separated according to different isoelectric points using anion-exchange chromatography and had similar activity. Approximately 1.4g TFPI 1-161(24kD) and 1.8g TFPI 1-161(27kD) was obtained from 4-liter fermentation culture after purification by ultrafiltration, gel filtration, anion-exchange chromatography. Their specific activity were up to 12 880u/mg and 12 400u/mg respectively. The rate of recovery of TFPI 1-161 was about 55%. The recombinant TFPI 1-161 had good anticoagulant activity in diluted prothrombin time assay (dPT) and anti-FXa activity in a direct amidolytic assay. The expression and purification system described here provides a cost-effective method for generating large amounts of material for further fundamental and preclinical research of TFPI 1-161.

Molecular Cloning, Expression and Characterization of Soluble Tissue Factor

Study on the Cloning and Expression of Human Fibrinogen α ,β, γ Gene

Study on the Cloning and Expression of Human Fibrinogen Α,β,γ Gene

Cloning and Expression of Tachypleus Tridentatus Factor C

[Molecular Cloning, Expression and Characterization of the Clones Encoding Soluble TF Mutants].

Production of Extracellular Domain of Human Tissue Factor Using Maltose-Binding Protein Fusion System.

Expression of Human Tissue Factor in SP2/0 Cells

Generation and Application of Active Recombinant Mouse Tissue Factor and Its Function-blocking Monoclonal Antibody

Expression and purification of the recombinant human tissue factor in Pichia pastoris

Expression, Purification and Characterization of Recombinant Human Coagulation Factor XIIIa in Pichia Pastoris

Preparation of anti-recombinant soluble tissue factor monoclonal antibody by trace injecting antigen into spleen

Experimental Study of Fibrinolytic Factors and Its Inhibitors in Rabbits' Tissues Extract.

Expression, Refolding, and Characterization of Recombinant Thrombopoietin/stem Cell Factor Fusion Protein in Escherichia Coli

Cloning and Expression of the Cdna Encoding Human Tissue Inhibitor of Metalloproteinase-3 and Its Inhibition on Angiogenesis

Cloning and Expression of One Fibrinolytic Enzyme from Bacillus Sp. Zlw-2

Expression, Purification, and Characterization of A Novel Recombinant Fusion Protein, Rhtpo/Scf, in Escherichia Coli

Cloning, Expression and Biological Characterization of Htfpi-2 Gene

Cloning of human thrombopoietin and it's expression in E. coli

High Expression and Characterization of Recombinant Deletion Variant TFPI1 - 161 of Human Tissue Factor Pathway Inhibitor in Pichia Pastoris

A Novel Anti-Tissue Factor Monoclonal Antibody with Anticoagulant Potency Derived from Synthesized Multiple Antigenic Peptide Through Blocking FX Combination with TF

Cloning and Expression of Human Fetal Cardiac Troponin T Isoform